Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation

Shota Kawakami, Kazuhiko Ochiai, Yuiko Kato, Masaki Michishita, Hinako Hirama, Ryo Obara, Daigo Azakami, Masami Watanabe, Toshinori Omi

Research output: Contribution to journalArticle

Abstract

Gliomas are common intracranial neoplasias in dogs. However, the underlying pathogenic mechanisms remain unclear. In humans, isocitrate dehydrogenase 2 (IDH2) is often mutated in gliomas. Although almost human IDH2 mutations have been identified at the Arg172 codon, few studies have reported structural, functional or mutational information for canine IDH2. In this study, we cloned the full-length canine IDH2 (cIDH2) cDNA and substituted wild type Arg174 (cIDH2 WT: corresponding to R172 of human IDH2) with Lys (cIDH2 R174K). The cIDH2 WT and R174K proteins were overexpressed in HeLa cells, and their presence was confirmed using an anti-human IDH2-WT mAb (clone: KrMab-3) and an anti-IDH2-R172K mAb (clone: KMab-1). The IDH2 activity between cIDH2 WT and cIDH2 R174K transfectants was compared by measuring the production of NADH and NADPH. NADPH production was lower for cIDH2 R174K than that for cIDH2 WT transfectants. Finally, we detected increased expression of hypoxia inducible factor-1 alpha (HIF-1α) in cIDH2 R174K transfectants. This indicates that mutations at R174 can potentially induce carcinogenesis in canine somatic cells.

Original languageEnglish
Pages (from-to)85-91
Number of pages7
JournalJournal of Veterinary Medical Science
Volume80
Issue number1
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Isocitrate Dehydrogenase
isocitrate dehydrogenase
Canidae
mutation
Mutation
dogs
NADP
Glioma
NADP (coenzyme)
Hypoxia-Inducible Factor 1
NAD (coenzyme)
HeLa Cells
Codon
NAD
somatic cells
codons
carcinogenesis
Carcinogenesis
Complementary DNA
Clone Cells

Keywords

  • Canine
  • Glioma
  • IDH2
  • Mutation

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Kawakami, S., Ochiai, K., Kato, Y., Michishita, M., Hirama, H., Obara, R., ... Omi, T. (2018). Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation. Journal of Veterinary Medical Science, 80(1), 85-91. https://doi.org/10.1292/jvms.17-0362

Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation. / Kawakami, Shota; Ochiai, Kazuhiko; Kato, Yuiko; Michishita, Masaki; Hirama, Hinako; Obara, Ryo; Azakami, Daigo; Watanabe, Masami; Omi, Toshinori.

In: Journal of Veterinary Medical Science, Vol. 80, No. 1, 01.01.2018, p. 85-91.

Research output: Contribution to journalArticle

Kawakami, S, Ochiai, K, Kato, Y, Michishita, M, Hirama, H, Obara, R, Azakami, D, Watanabe, M & Omi, T 2018, 'Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation', Journal of Veterinary Medical Science, vol. 80, no. 1, pp. 85-91. https://doi.org/10.1292/jvms.17-0362
Kawakami, Shota ; Ochiai, Kazuhiko ; Kato, Yuiko ; Michishita, Masaki ; Hirama, Hinako ; Obara, Ryo ; Azakami, Daigo ; Watanabe, Masami ; Omi, Toshinori. / Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation. In: Journal of Veterinary Medical Science. 2018 ; Vol. 80, No. 1. pp. 85-91.
@article{2a84b0acd564409da2616c69cc9f352d,
title = "Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation",
abstract = "Gliomas are common intracranial neoplasias in dogs. However, the underlying pathogenic mechanisms remain unclear. In humans, isocitrate dehydrogenase 2 (IDH2) is often mutated in gliomas. Although almost human IDH2 mutations have been identified at the Arg172 codon, few studies have reported structural, functional or mutational information for canine IDH2. In this study, we cloned the full-length canine IDH2 (cIDH2) cDNA and substituted wild type Arg174 (cIDH2 WT: corresponding to R172 of human IDH2) with Lys (cIDH2 R174K). The cIDH2 WT and R174K proteins were overexpressed in HeLa cells, and their presence was confirmed using an anti-human IDH2-WT mAb (clone: KrMab-3) and an anti-IDH2-R172K mAb (clone: KMab-1). The IDH2 activity between cIDH2 WT and cIDH2 R174K transfectants was compared by measuring the production of NADH and NADPH. NADPH production was lower for cIDH2 R174K than that for cIDH2 WT transfectants. Finally, we detected increased expression of hypoxia inducible factor-1 alpha (HIF-1α) in cIDH2 R174K transfectants. This indicates that mutations at R174 can potentially induce carcinogenesis in canine somatic cells.",
keywords = "Canine, Glioma, IDH2, Mutation",
author = "Shota Kawakami and Kazuhiko Ochiai and Yuiko Kato and Masaki Michishita and Hinako Hirama and Ryo Obara and Daigo Azakami and Masami Watanabe and Toshinori Omi",
year = "2018",
month = "1",
day = "1",
doi = "10.1292/jvms.17-0362",
language = "English",
volume = "80",
pages = "85--91",
journal = "Journal of Veterinary Medical Science",
issn = "0916-7250",
publisher = "Japanese Society of Veterinary Science",
number = "1",

}

TY - JOUR

T1 - Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation

AU - Kawakami, Shota

AU - Ochiai, Kazuhiko

AU - Kato, Yuiko

AU - Michishita, Masaki

AU - Hirama, Hinako

AU - Obara, Ryo

AU - Azakami, Daigo

AU - Watanabe, Masami

AU - Omi, Toshinori

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Gliomas are common intracranial neoplasias in dogs. However, the underlying pathogenic mechanisms remain unclear. In humans, isocitrate dehydrogenase 2 (IDH2) is often mutated in gliomas. Although almost human IDH2 mutations have been identified at the Arg172 codon, few studies have reported structural, functional or mutational information for canine IDH2. In this study, we cloned the full-length canine IDH2 (cIDH2) cDNA and substituted wild type Arg174 (cIDH2 WT: corresponding to R172 of human IDH2) with Lys (cIDH2 R174K). The cIDH2 WT and R174K proteins were overexpressed in HeLa cells, and their presence was confirmed using an anti-human IDH2-WT mAb (clone: KrMab-3) and an anti-IDH2-R172K mAb (clone: KMab-1). The IDH2 activity between cIDH2 WT and cIDH2 R174K transfectants was compared by measuring the production of NADH and NADPH. NADPH production was lower for cIDH2 R174K than that for cIDH2 WT transfectants. Finally, we detected increased expression of hypoxia inducible factor-1 alpha (HIF-1α) in cIDH2 R174K transfectants. This indicates that mutations at R174 can potentially induce carcinogenesis in canine somatic cells.

AB - Gliomas are common intracranial neoplasias in dogs. However, the underlying pathogenic mechanisms remain unclear. In humans, isocitrate dehydrogenase 2 (IDH2) is often mutated in gliomas. Although almost human IDH2 mutations have been identified at the Arg172 codon, few studies have reported structural, functional or mutational information for canine IDH2. In this study, we cloned the full-length canine IDH2 (cIDH2) cDNA and substituted wild type Arg174 (cIDH2 WT: corresponding to R172 of human IDH2) with Lys (cIDH2 R174K). The cIDH2 WT and R174K proteins were overexpressed in HeLa cells, and their presence was confirmed using an anti-human IDH2-WT mAb (clone: KrMab-3) and an anti-IDH2-R172K mAb (clone: KMab-1). The IDH2 activity between cIDH2 WT and cIDH2 R174K transfectants was compared by measuring the production of NADH and NADPH. NADPH production was lower for cIDH2 R174K than that for cIDH2 WT transfectants. Finally, we detected increased expression of hypoxia inducible factor-1 alpha (HIF-1α) in cIDH2 R174K transfectants. This indicates that mutations at R174 can potentially induce carcinogenesis in canine somatic cells.

KW - Canine

KW - Glioma

KW - IDH2

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=85041134215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041134215&partnerID=8YFLogxK

U2 - 10.1292/jvms.17-0362

DO - 10.1292/jvms.17-0362

M3 - Article

C2 - 29162772

AN - SCOPUS:85041134215

VL - 80

SP - 85

EP - 91

JO - Journal of Veterinary Medical Science

JF - Journal of Veterinary Medical Science

SN - 0916-7250

IS - 1

ER -